表紙
市場調查報告書

HIV/AIDS免疫測量診斷市場:全球產業分析,規模,佔有率,成長,趨勢,預測(2019∼2027年)

HIV/AIDS Immunoassay Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

出版商 Transparency Market Research 商品編碼 920539
出版日期 內容資訊 英文 175 Pages
商品交期: 最快1-2個工作天內
價格
HIV/AIDS免疫測量診斷市場:全球產業分析,規模,佔有率,成長,趨勢,預測(2019∼2027年) HIV/AIDS Immunoassay Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
出版日期: 2019年12月13日內容資訊: 英文 175 Pages
簡介

本報告提供HIV/AIDS免疫測量診斷市場相關調查,彙整市場趨勢與預測,市場規模,主要加入企業,各地區趨勢相關資訊。

第1章 序論

第2章 假設和調查方法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 概要
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
  • 市場分析與預測

第5章 市場預測

  • 技術進步
  • 主要的產業趨勢
  • 各地區免疫測量診斷檢驗數
  • 價格分析

第6章 市場價值與預測:各產品

  • 簡介和定義
  • 市場價值預測
    • 分析設備
    • 套件·試劑
  • 市場魅力度

第7章 市場價值與預測:各技術

  • 簡介和定義
  • 市場價值預測
    • ELISA
    • CLIA
    • 其他
  • 市場魅力度

第8章 市場價值與預測:各終端用戶

  • 簡介和定義
  • 市場價值預測
    • 醫院
    • 診斷測試所
    • 血庫
    • 其他
  • 市場魅力度

第9章 市場價值與預測:各地區

  • 簡介
  • 市場價值預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力度

第10章 北美

第11章 歐洲

第12章 亞太地區

第13章 南美

第14章 中東·非洲

第15章 競爭環境

  • 競爭矩陣
  • 市場佔有率分析
  • 企業簡介
目錄

Scope of the Report

TMR's report on the global HIV/AIDS immunoassay diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of same indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global HIV/AIDS immunoassay diagnostics market for the period of 2017-2027, where 2018 is the base year and 2027 is the forecast year. The report also provides the compound annual growth rate (CAGR) for the global HIV/AIDS immunoassay diagnostics market for the forecast period.

The report has been prepared after an extensive research. Primary research involves bulk of research efforts, wherein, analysts have carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players' product literature, annual reports, press releases, articles, journals, and relevant documents to understand the global HIV/AIDS immunoassay diagnostics market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a bottom-up approach to study various phenomena in the global HIV/AIDS immunoassay diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global HIV/AIDS immunoassay diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global HIV/AIDS immunoassay diagnostics market. The next section of the global HIV/AIDS immunoassay diagnostics report highlights the USPs, which include key industry developments, technological advancements, epidemiology analysis, immunoassay diagnostic tests for HIV/AIDS, and pricing analysis in the global HIV/AIDS immunoassay diagnostics market.

The report delves into the competition landscape of the global HIV/AIDS immunoassay diagnostics market. Key players operating in the global HIV/AIDS immunoassay diagnostics market have been identified and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global HIV/AIDS immunoassay diagnostics market profiled in this report.

Key Questions Answered:

  • What are the major drivers, restraints, and opportunities in the global HIV/AIDS immunoassay diagnostics market?
  • What will be the revenue share projections of key segments in the global HIV/AIDS immunoassay diagnostics market during the forecast period?
  • Which segment is likely to lead the global HIV/AIDS immunoassay diagnostics market in terms of revenue by 2027?
  • How mergers & acquisitions among players are widening the scope for the global HIV/AIDS immunoassay diagnostics market?
  • Which are the leading companies in the global HIV/AIDS immunoassay diagnostics market?

Research Objectives and Research Approach

The comprehensive report on the global HIV/AIDS immunoassay diagnostics market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides a detailed explanation of the objectives behind this study and health care compliances laid down by accredited agencies in the purview of the research in the global HIV/AIDS immunoassay diagnostics market. It is followed by market introduction, market dynamics, and an overview of the global HIV/AIDS immunoassay diagnostics market, which include TMR analysis of market drivers, restraints, and trends affecting the growth of the global HIV/AIDS immunoassay diagnostics market. Furthermore, to understand the Y-o-Y trends of the HIV/AIDS immunoassay diagnostics market, a Y-o-Y analysis with elaborated insights on the same has been provided. The next section of the global HIV/AIDS immunoassay diagnostics report highlights the USPs, which include HIV/AIDS immunoassay diagnostics: key industry developments, technological advancements, epidemiology analysis, immunoassay diagnostic tests for HIV/AIDS, and pricing analysis.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global HIV/AIDS immunoassay diagnostics market in terms of product, technology, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of them at the end of 2027 has been provided herein. Such valuable insights enable market stakeholders in making informed business decisions for investments in the global HIV/AIDS immunoassay diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global HIV/AIDS Immunoassay Diagnostics Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

  • 5.1. Technological Advancements
  • 5.2. Key Industry Developments
  • 5.3. Epidemiology Analysis
  • 5.4. Number of HIV/AIDS Immunoassay Diagnostics Tests, by Region
  • 5.5. Pricing Analysis

6. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Global HIV/AIDS Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
    • 6.2.1. Analyzers
    • 6.2.2. Kits & Reagents
  • 6.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product

7. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Technology

  • 7.1. Introduction
  • 7.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027
    • 7.2.1. ELISA
    • 7.2.2. CLIA
    • 7.2.3. Others
  • 7.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology

8. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by End User

  • 8.1. Introduction
  • 8.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027
    • 8.2.1. Hospitals
    • 8.2.2. Diagnostic Laboratories
    • 8.2.3. Blood Banks
    • 8.2.4. Others
  • 8.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User

9. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Region

  • 9.1. Introduction
  • 9.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2027
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Region

10. North America HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027
    • 10.2.1. Analyzers
    • 10.2.2. Kits & Reagents
  • 10.3. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027
    • 10.3.1. ELISA
    • 10.3.2. CLIA
    • 10.3.3. Others
  • 10.4. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027
    • 10.4.1. Hospitals
    • 10.4.2. Diagnostic Laboratories
    • 10.4.3. Blood Banks
    • 10.4.4. Others
  • 10.5. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2027
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Technology
    • 10.6.3. By End User
    • 10.6.4. By Country

11. Europe HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027
    • 11.2.1. Analyzers
    • 11.2.2. Kits & Reagents
  • 11.3. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027
    • 11.3.1. ELISA
    • 11.3.2. CLIA
    • 11.3.3. Others
  • 11.4. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027
    • 11.4.1. Hospitals
    • 11.4.2. Diagnostic Laboratories
    • 11.4.3. Blood Banks
    • 11.4.4. Others
  • 11.5. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Russia
    • 11.5.7. Rest of Europe
  • 11.6. Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Technology
    • 11.6.3. By End User
    • 11.6.4. By Country/Sub-region

12. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027
    • 12.2.1. Analyzers
    • 12.2.2. Kits & Reagents
  • 12.3. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027
    • 12.3.1. ELISA
    • 12.3.2. CLIA
    • 12.3.3. Others
  • 12.4. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027
    • 12.4.1. Hospitals
    • 12.4.2. Diagnostic Laboratories
    • 12.4.3. Blood Banks
    • 12.4.4. Others
  • 12.5. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 12.5.1. Japan
    • 12.5.2. China
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Technology
    • 12.6.3. By End User
    • 12.6.4. By Country/Sub-region

13. Latin America HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027
    • 13.2.1. Analyzers
    • 13.2.2. Kits & Reagents
  • 13.3. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027
    • 13.3.1. ELISA
    • 13.3.2. CLIA
    • 13.3.3. Others
  • 13.4. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027
    • 13.4.1. Hospitals
    • 13.4.2. Diagnostic Laboratories
    • 13.4.3. Blood Banks
    • 13.4.4. Others
  • 13.5. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Technology
    • 13.6.3. By End User
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027
    • 14.2.1. Analyzers
    • 14.2.2. Kits & Reagents
  • 14.3. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027
    • 14.3.1. ELISA
    • 14.3.2. CLIA
    • 14.3.3. Others
  • 14.4. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027
    • 14.4.1. Hospitals
    • 14.4.2. Diagnostic Laboratories
    • 14.4.3. Blood Banks
    • 14.4.4. Others
  • 14.5. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Technology
    • 14.6.3. By End User
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Global HIV/AIDS Immunoassay Diagnostics Market Share Analysis, by Company (2018)
  • 15.3. Company Profiles
    • 15.3.1. F. Hoffmann-La Roche Ltd.
      • 15.3.1.1. Company Description
      • 15.3.1.2. Business Overview
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. Strategic Overview
      • 15.3.1.5. SWOT Analysis
    • 15.3.2. Bio-Rad Laboratories, Inc.
      • 15.3.2.1. Company Description
      • 15.3.2.2. Business Overview
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. Strategic Overview
      • 15.3.2.5. SWOT Analysis
    • 15.3.3. Siemens Healthineers AG.
      • 15.3.3.1. Company Description
      • 15.3.3.2. Business Overview
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. Strategic Overview
      • 15.3.3.5. SWOT Analysis
    • 15.3.4. DiaSorin S.p.A.
      • 15.3.4.1. Company Description
      • 15.3.4.2. Business Overview
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. Strategic Overview
      • 15.3.4.5. SWOT Analysis
    • 15.3.5. Abbott Laboratories
      • 15.3.5.1. Company Description
      • 15.3.5.2. Business Overview
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. Strategic Overview
      • 15.3.5.5. SWOT Analysis
    • 15.3.6. Ortho Clinical Diagnostics (a part of Carlyle Group)
      • 15.3.6.1. Company Description
      • 15.3.6.2. Business Overview
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. Strategic Overview
      • 15.3.6.5. SWOT Analysis
    • 15.3.7. Shenzhen New Industries Biomedical Engineering Co., Ltd.
      • 15.3.7.1. Company Description
      • 15.3.7.2. Business Overview
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. Strategic Overview
      • 15.3.7.5. SWOT Analysis
    • 15.3.8. bioMerieux SA
      • 15.3.8.1. Company Description
      • 15.3.8.2. Business Overview
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. Strategic Overview
      • 15.3.8.5. SWOT Analysis
    • 15.3.9. Fujirebio (Miraca Group)
      • 15.3.9.1. Company Description
      • 15.3.9.2. Business Overview
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. Strategic Overview
      • 15.3.9.5. SWOT Analysis

List of Tables

  • Table 01: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 02: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • Table 03: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027
  • Table 04: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 05: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 06: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 07: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • Table 08: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027
  • Table 09: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 10: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 11: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • Table 12: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027
  • Table 13: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 14: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 15: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • Table 16: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027
  • Table 17: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 18: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 19: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • Table 20: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027
  • Table 21: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 22: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027
  • Table 23: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027
  • Table 24: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027

List of Figures

  • Figure 01: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2027
  • Figure 02: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2027
  • Figure 03: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018
  • Figure 04: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018
  • Figure 05: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018
  • Figure 06: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Region, 2018
  • Figure 07: HIV/AIDS Immunoassay Diagnostics Market - Mergers, Acquisitions, Collaborations, Partnerships & New Product Launch
  • Figure 08: Technological Advancements
  • Figure 09: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027
  • Figure 10: Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019-2027
  • Figure 11: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzers, 2017-2027
  • Figure 12: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Kits & Reagents, 2017-2027
  • Figure 13: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027
  • Figure 14: Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019-2027
  • Figure 15: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by ELISA, 2017-2027
  • Figure 16: Global Ne HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CLIA, 2017-2027
  • Figure 17: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 18: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027
  • Figure 19: Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019-2027
  • Figure 20: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2027
  • Figure 21: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2017-2027
  • Figure 22: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Banks, 2017-2027
  • Figure 23: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 24: Global HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 25: Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Region, 2019-2027
  • Figure 26: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 27: North America HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 28: North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 29: North America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027
  • Figure 30: North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019-2027
  • Figure 31: North America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027
  • Figure 32: North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019-2027
  • Figure 33: North America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027
  • Figure 34: North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019-2027
  • Figure 35: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 36: Europe HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 37: Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 38: Europe HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027
  • Figure 39: Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019-2027
  • Figure 40: Europe HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027
  • Figure 41: Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019-2027
  • Figure 42: Europe HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027
  • Figure 43: Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019-2027
  • Figure 44: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 45: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 46: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 47: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027
  • Figure 48: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019-2027
  • Figure 49: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027
  • Figure 50: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019-2027
  • Figure 51: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027
  • Figure 52: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019-2027
  • Figure 53: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 54: Latin America HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 55: Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 56: Latin America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027
  • Figure 57: Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019-2027
  • Figure 58: Latin America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027
  • Figure 59: Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019-2027
  • Figure 60: Latin America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027
  • Figure 61: Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019-2027
  • Figure 62: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2027
  • Figure 63: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 64: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 65: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027
  • Figure 66: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019-2027
  • Figure 67: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027
  • Figure 68: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019-2027
  • Figure 69: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027
  • Figure 70: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019-2027
  • Figure 71: Global HIV/AIDS Immunoassay Diagnostics Market Share Analysis, by Company, 2018